Olfactory Training as a Treatment for Olfactory Dysfunction Post COVID-19

Recruiting N/A Interventional Study
Hyposmia COVID-19 Parosmia Anosmia SARS-CoV-2 Infection
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
70 (estimated)
Sponsor
Université du Québec à Trois-Rivières · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Olfactory dysfunction is a defining symptom of COVID-19 infection. Studies have demonstrated improved olfaction in patients with post infectious olfactory dysfunction after an olfactory training (OT). The aim of this study is to assess the clinical outcomes of olfactory training (12 weeks) therapy in the treatment of persistent olfactory dysfunctions after COVID-19. Specially, we aim to compare th…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patient diagnosed positive for COVID-19 with persistent olfactory dysfunction * Willing and able to provide written informed consent * Understand and read the French language * Have an internet connection and a working email address Exclusion Criteria: * Anosmia and hyposmia…
Contacts

Johannes A Frasnelli, PhD

18193765011

johannes.a.frasnelli@uqtr.ca

CONTACT

Frank Cloutier, PhD

18193765011

frank.cloutier@uqtr.ca

CONTACT